 |
5-[1-(2,6-Dichlorobenzyl)-piperidin-4-yl]methoxyquinazoline-2,4-diamine |
|---|---|
| Trade Name | |
| Orphan Indication | Spinal muscular atrophy |
| USA Market Approval | USA |
| USA Designation Date | 2009-08-25 00:00:00 |
| Sponsor | CureSMA;925 Busse Avenue;Elk Grove Village, Illinois, 60007 |
Related Access Program
Pfizer – Non Small Cell Lung Cancer With ALK or ROS1 Rearrangement
Pfizer – Non Small Cell Lung Cancer Harboring Molecular Alterations
Biogen – Infantile-onset Spinal Muscular Atrophy
Novartis Pharmaceuticals – Non-small Cell Lung Cancer (NSCLC)
Biogen – Infantile-onset Spinal Muscular Atrophy (SMA)